These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3580413)
1. [Metabolism of exogenous phosphocreatine and 3-phosphono-2-imino-1-methyl-4-hydroxy-imidazoline in the perfused rat heart during ischemia]. Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Zueva MIu; Kapel'ko VI Biokhimiia; 1987 Mar; 52(3):437-45. PubMed ID: 3580413 [TBL] [Abstract][Full Text] [Related]
2. [3-Phosphono-2-imino-4-oxoimidazoline--a competitive substrate of AMP-dephosphorylating enzymes from the cytosol fraction of the rat heart]. Shteĭnshneĭder AIa; Kupriianov VV; Ruuge EK; Saks VA Biokhimiia; 1987 Apr; 52(4):577-83. PubMed ID: 3593790 [TBL] [Abstract][Full Text] [Related]
3. [Effect of phosphocreatine on the lysophosphoglyceride levels in total ischemia of the rat myocardium]. Dzhavadov SA; Preobrazhenskiĭ AN; Saks VA Biokhimiia; 1986 Apr; 51(4):668-74. PubMed ID: 3708016 [TBL] [Abstract][Full Text] [Related]
4. The role of phosphocreatine and ATP in contraction of normal and ischemic heart. Kupriyanov VV; Lakomkin VL; Steinschneider AYa ; Novikova NA; Severina MYu ; Kapelko VI; Saks VA Biomed Biochim Acta; 1987; 46(8-9):S493-8. PubMed ID: 3435507 [TBL] [Abstract][Full Text] [Related]
5. [Possible mechanism of the protective effect of phosphocreatine on the ischemic myocardium]. Preobrazhenskiĭ AN; Dzhavadov SA; Saks VA Biokhimiia; 1986 Apr; 51(4):675-83. PubMed ID: 3011127 [TBL] [Abstract][Full Text] [Related]
6. Effect of creatine monohydrate on cardiac function in a rat model of endotoxemia. Vona-Davis L; Wearden PD; Karne NH; Hill RC J Surg Res; 2002 Mar; 103(1):1-7. PubMed ID: 11855910 [TBL] [Abstract][Full Text] [Related]
7. Accelerated recovery of ischemic canine myocardium induced by AMP. Preliminary report. Sami HM; Koke JR; Bittar N Adv Myocardiol; 1985; 6():483-90. PubMed ID: 3992046 [TBL] [Abstract][Full Text] [Related]
8. [Study of the protective effect of phosphocreatine on the ischemic myocardium during cardioplegia using the P-31 NMR method]. Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Ruuge EK; Kapel'ko VI Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):14-9. PubMed ID: 4005052 [TBL] [Abstract][Full Text] [Related]
9. Relative abilities of phosphagens with different thermodynamic or kinetic properties to help sustain ATP and total adenylate pools in heart during ischemia. Turner DM; Walker JB Arch Biochem Biophys; 1985 May; 238(2):642-51. PubMed ID: 3994395 [TBL] [Abstract][Full Text] [Related]
10. Contractility, ATP, and creatine phosphate during myocardial ischaemia and reperfusion: the effects of adenosine and inhibition of adenosine catabolism in the dog heart. Wu SQ; Fu LM; Koke JR; Bittar N Cytobios; 1987; 50(200):7-12. PubMed ID: 3581918 [TBL] [Abstract][Full Text] [Related]
11. [Characterization of the state of cardiac energy metabolism using NMR spectroscopy of 31P: comparison with biochemical data]. Lavanchy N; Martin J; Rossi A J Physiol (Paris); 1985; 80(3):196-201. PubMed ID: 4087211 [TBL] [Abstract][Full Text] [Related]
12. [Adenosine nucleotide metabolism of the myocardium]. Müller MM; Mohl W; Schopf G Z Med Lab Diagn; 1985; 26(2):71-6. PubMed ID: 3993166 [No Abstract] [Full Text] [Related]
13. The effect of thiamine deficiency upon the contractility and metabolism of the isolated perfused rat heart. Hauschildt S; Tan CH; Hall A; Olson RE Int J Vitam Nutr Res; 1973 Apr; 43(4):416-25. PubMed ID: 4769336 [No Abstract] [Full Text] [Related]
14. [The role of calcium ions in the molecular mechanism of the protective mechanism of exogenous phosphocreatine]. Dzhaliashvili IV; Konorev EA; Medvedeva NV; Lakomkin VL; Saks VA Biokhimiia; 1992 Feb; 57(2):300-11. PubMed ID: 1326338 [TBL] [Abstract][Full Text] [Related]
15. Metabolic deterioration during global ischemia as a function of time in the intact normal dog heart. Jones RN; Attarian DE; Currie WD; Olsen CO; Hill RC; Sink JD; Wechsler AS J Thorac Cardiovasc Surg; 1981 Feb; 81(2):264-73. PubMed ID: 7453237 [TBL] [Abstract][Full Text] [Related]
16. 31P-MRS study of bio-energy recovering phenomenon. Yoshiyama M; Sakai H; Teragaki M; Takeuchi K; Takeda T; Ikata M; Ishikawa M; Miura I Biochem Biophys Res Commun; 1988 Mar; 151(2):865-71. PubMed ID: 3348817 [TBL] [Abstract][Full Text] [Related]
17. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization. Prabhakar G; Vona-Davis L; Murray D; Lakhani P; Murray G J Am Coll Surg; 2003 Nov; 197(5):786-91. PubMed ID: 14585415 [TBL] [Abstract][Full Text] [Related]
18. Determination of buffering capacity of rat myocardium during ischemia. Wolfe CL; Gilbert HF; Brindle KM; Radda GK Biochim Biophys Acta; 1988 Aug; 971(1):9-20. PubMed ID: 2841984 [TBL] [Abstract][Full Text] [Related]
19. The effect of intravenously administered phosphocreatine on ATP and phosphocreatine concentrations in the cardiac muscle of the rat. Down WH; Chasseaud LF; Ballard SA Arzneimittelforschung; 1983; 33(4):552-4. PubMed ID: 6683532 [TBL] [Abstract][Full Text] [Related]
20. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies. Sharov VG; Saks VA; Kupriyanov VV; Lakomkin VL; Kapelko VI; Steinschneider AYa ; Javadov SA J Thorac Cardiovasc Surg; 1987 Nov; 94(5):749-61. PubMed ID: 3669703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]